Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
Story summary
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
📌 Key Highlights & Takeaways
- The round valued the AI biotech at $2 billion.
- It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
Cryptographic Security & Key Generator
Generate entropy-tested high-security keys and encryption-grade tokens.
Source: TechCrunch.
Next-Gen Neural Compute Sandbox & Open-Source AI Architecture Specifications
Discover next-generation artificial intelligence breakthroughs, futuristic cyberpunk gadgets, robotics, and science innovations.
Access AI Sandbox ➔🔬 Full AI Technical Analysis & Dataset
Download complete neural architecture specs and open benchmarks.
⚡ Access Research Portal ➔More from CyberTech 568
🤖 WinBar AI
Ex-DraftKings staff say AI targeted free bets to gamblers most likely to keep losing
Breaking coverage reported by The Cool Down: Ex-DraftKings staff say AI targeted free bets to gamblers most li...
☁️ FreeSky Cloud
Scale your own way, using HPA with built-in support for PromQL metrics queries in GKE
Earlier this year, we announced native support for Google Kubernetes Engine (GKE) custom metrics. This milesto...
🛰️ FreeSky Aerial
NASA Aircraft to Make Low-Altitude Research Flights Over Colorado
Agricultural emissions represent an important and understudied part of Earth’s land and atmosphere systems. Th...
Hubble Captures Amazing View Of Spiral Galaxy That Is 30 Million Light-Years Away
The Hubble Space Telescope has captured imagery of spiral galaxy UGC 2890. The "galaxy lies around 30 million ...